GGrantIndex
← Leaderboards

Mmj Labs, Llc

Atlanta, GA

Compare ↔
$3,488,329
Total funding
3
Grants

Funding over time

peak $811.5K · FY200925
$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,488,329 · 3

By mechanism

R44$3,488,329 · 3

Investigators at Mmj Labs, Llc

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$811,478
R44 · FY2020 · DA
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$688,522
R44 · FY2021 · DA
Relieving Pediatric Immunization Pain Using A Reusable Personal Device$469,334
R44 · FY2009 · HD
Relieving Pediatric Immunization Pain Using A Reusable Personal Device$468,634
R44 · FY2010 · HD
Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)$455,972
R44 · FY2025 · DA
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$221,959
R44 · FY2019 · DA
Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)$159,110
R44 · FY2023 · DA
Relieving Pediatric Immunization Pain Using A Reusable Personal Device$123,920
R44 · FY2009 · HD
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$89,400
R44 · FY2023 · DA